Biogen Idec, Inc. (Massachusetts), Roche Holding AG’s Genentech End Dispute Over Rituxan Follow-Ons

Oct 21 (Reuters) - Biogen Idec Inc (BIIB.O) and Roche Holding AG's (ROG.VX) Genentech unit agreed to amend the terms of their collaboration to develop antibody drugs, ending a long-term dispute.
MORE ON THIS TOPIC